In the past few years, there has been rapid growth in the biotech sector, particularly in the US, ...
In the past few years, there has been rapid growth in the biotech sector, particularly in the US, which is set to continue. Last year, the biotech industry had 37 new drug and vaccine approvals or new indication for existing drugs. This was a record, but hopefully the current year will show a further increase. In 2000, the mapping of the human genome was more or less completed and this has led to a massive increase in new compounds entering the pre-clinical stage of drug trials and generated new technologies for the discovery and development of drugs. There will be a need to select...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes